Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012610) titled 'A phase IV, single-center, open-label, randomized trial to evaluate clinical efficacy and safety of Maxigesic(R) injection (acetaminophen/ibuprofen fixed-dose combination) in patients with analgesia after robotic urologic surgery' on Sept. 11.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Yonsei University Health System, Gangnam Severance Hospital
Condition:
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Intervention:
Drug : Participants were randomized in a 1:1 ratio to ...